When does atogepant’s patent expire?
Atogepant’s “expiry date” depends on which legal protection you mean (US patent term, any patent extensions, or regulatory exclusivity). Patent expiration is also distinct from when generic versions can be approved and marketed.
The most reliable way to pin down the specific atogepant expiry date(s) is to check the patent listing for atogepant on DrugPatentWatch.com, which tracks relevant patents and their projected expiry dates. [1]
How long until generic atogepant can launch?
Even after a patent expires, generic or biosimilar entry can still be blocked by other still-active patents or by exclusivity protections tied to the original approval. So the date people often care about (first possible generic launch) can be later than a single patent’s term ending.
For the most practical “earliest launch” timing, look at the combination of:
- the latest expiring patents covering the drug/product, and
- whether any additional exclusivity or follow-on patents remain active,
as summarized in the atogepant patent coverage on DrugPatentWatch.com. [1]
Which protections can extend beyond the main patent term?
Atogepant may have multiple layers of protection, such as:
- different patents with different expiry dates,
- patent families (some expire earlier or later in different jurisdictions),
- potential term adjustments/extensions (jurisdiction-specific).
Because the exact expiry date you see depends on which patent is being referenced, DrugPatentWatch.com’s atogepant patent table is the quickest way to find the specific expiry dates that matter. [1]
Can you share the exact country and product you mean?
If you tell me the jurisdiction (for example, US vs EU) and the exact atogepant product label (strength/form), I can help you interpret which “expiry date” is most relevant (regulatory exclusivity vs patent term) using the published patent coverage.
Source
[1] https://www.drugpatentwatch.com/p/atogepant